Brilinta and Atrial fibrillation aggravated - a phase IV clinical study of FDA data
Atrial fibrillation aggravated is found among people who take Brilinta, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Brilinta and have Atrial fibrillation aggravated. It is created by eHealthMe based on reports of 20,036 people who have side effects when taking Brilinta from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
20,036 people reported to have side effects when taking Brilinta.
Among them, 209 people (1.04%) have Atrial fibrillation aggravated.
What is Brilinta?
Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 20,317 Brilinta users for its effectiveness, alternative drugs and more.
What is Atrial fibrillation aggravated?
Atrial fibrillation aggravated (serious fibrillation of the muscles of the atria of the heart) is found to be associated with 1,479 drugs and 669 conditions by eHealthMe.
Number of Brilinta and Atrial fibrillation aggravated reports submitted per year:
Time on Brilinta when people have Atrial fibrillation aggravated *:
Gender of people who have Atrial fibrillation aggravated when taking Brilinta*:
Age of people who have Atrial fibrillation aggravated when taking Brilinta *:
Common drugs people take besides Brilinta *:
Common side effects people have besides Atrial fibrillation aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Brilinta and have Atrial fibrillation aggravated?Check whether Atrial fibrillation aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Atrial fibrillation aggravated and when was it recovered:
Expand to all the drugs that have ingredients of ticagrelor:
Alternative drugs to, pros and cons of Brilinta:
- Brilinta (20,317 reports)
Common Brilinta side effects:
Browse all side effects of Brilinta:a b c d e f g h i j k l m n o p q r s t u v w x y z
Atrial fibrillation aggravated treatments and more:
- Atrial fibrillation aggravated (654 reports)
COVID vaccines that are related to Atrial fibrillation aggravated:
- Atrial fibrillation aggravated in Moderna COVID Vaccine
- Atrial fibrillation aggravated in Pfizer BioNTech Covid Vaccine
- Atrial fibrillation aggravated in Johnson and Johnson Covid Vaccine
Common drugs associated with Atrial fibrillation aggravated:
All the drugs that are associated with Atrial fibrillation aggravated:
- Atrial fibrillation aggravated (1,479 drugs)
Common conditions associated with Atrial fibrillation aggravated:
All the conditions that are associated with Atrial fibrillation aggravated:
- Atrial fibrillation aggravated (669 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ticagrelor (the active ingredients of Brilinta) and Brilinta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Apricot Kernel and Zithromax drug interaction - 34 seconds ago
- Ropinirole Hydrochloride and Psychotic Disorder - 38 seconds ago
- Depo-Provera and Pneumonia Aspiration - 49 seconds ago
- Dimethyl Fumarate and Narcolepsy - a minute ago
- Pneumonia and Renal Impairment - a minute ago
- Neurontin and Sciatica - a minute ago
- Meloxicam and Granuloma Annulare - a minute ago
- Mevacor and Bacterial Infection - a minute ago
- Amitiza and Joint Pain - 2 minutes ago
- Tikosyn and Neck Pain - 2 minutes ago